Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 12, 2004. The report details specific corporate actions regarding share buybacks and changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The only financial metrics disclosed relate to specific share transactions:
- Share Repurchase Price: 1,199.40 pence per share.
- Director Share Purchase Price: 11.80 pounds per share.
- Treasury Shares Held: 52,028,000 shares (post-transaction).
- Shares in Issue: 5,884,366,531 shares (excluding treasury shares).
Material Changes
The primary material change reported is a reduction in the company's share capital through a treasury share purchase:
- Share Buyback: On November 11, 2004, the company purchased 700,000 Ordinary Shares under authority granted at the May 17, 2004 Annual General Meeting.
- Director Transactions:
- Mr. J D Coombe acquired 22 Ordinary Shares (11 personal, 11 company-matched) via the ShareReward Plan on November 9, 2004.
- The GSK Trust transferred shares to employees under the SmithKline Beecham Employee Share Option Plan 1991 on three separate dates: 22,140 shares (Nov 10), 6,650 shares (Nov 11), and 28,094 shares (Sept 13).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It includes a standard disclaimer stating that the announcement does not constitute an offer or solicitation to purchase securities in any jurisdiction. No specific risks or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the total number of treasury shares held (52,028,000) against the company's latest annual report.
- Confirm the remaining authority for share buybacks following the purchase of 700,000 shares.
- Review the terms of the SmithKline Beecham Employee Share Option Plan 1991 regarding the recent trust transfers.
- Check the current market price of GSK shares to compare against the buyback price of 1,199.40 pence.